Exploring the the FDA’s Newly Proposed OTC Hearing Aid Rule and the Medicare Hearing Benefit

November 8, 2021

Published by Hearing Health Matters


Brandon Sawalich, President and CEO of Starkey, returns to This Week in Hearing to follow-up with Dr. Bob Traynor to discuss the FDA’s latest decision to release the draft OTC hearing aid rule, as well as the new Medicare Hearing Benefit currently under consideration in Congress – part of a much larger spending bill the White House hopes to pass in the coming weeks.


The pair discuss the implications of both the draft OTC rule, as well as the Medicare hearing benefit, on patients, providers and the overall industry.



Be sure to subscribe to the TWIH YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter.


SOURCE: Hearing Health Matters